BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18626738)

  • 1. A case of Vibrio vulnificus keratitis.
    You IC; Ahn M; Yoon KW; Yoon KC
    Jpn J Ophthalmol; 2008; 52(2):131-133. PubMed ID: 18626738
    [No Abstract]   [Full Text] [Related]  

  • 2. Vibrio vulnificus corneal ulcer: rapid resolution of a virulent pathogen.
    Massey EL; Weston BC
    Cornea; 2000 Jan; 19(1):108-9. PubMed ID: 10632019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V; Sharma N; Satpathy G; Titiyal J
    J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Kingella denitrificans from a corneal ulcer.
    Kim YH; Panday V; Reilly C
    Cornea; 2011 Apr; 30(4):472-3. PubMed ID: 21099406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serratia marcescens keratitis after photorefractive keratectomy.
    Rahimi F; Hashemian MN; Khodabande A
    J Cataract Refract Surg; 2009 Sep; 35(9):1645-6. PubMed ID: 19683170
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis.
    Inoue H; Suzuki T; Inoue T; Hattori T; Nejima R; Todokoro D; Hoshi S; Eguchi H; Miyamoto H; Ohashi Y
    Cornea; 2015 Sep; 34(9):1105-9. PubMed ID: 25970435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas keratitis after laser in situ keratomileusis.
    Sharma N; Sinha R; Singhvi A; Tandon R
    J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Bashir H; Dave A; Mathur U
    Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis.
    Liang SY; Lee GA
    J Cataract Refract Surg; 2011 May; 37(5):960-2. PubMed ID: 21511159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roseomonas keratitis after remote penetrating keratoplasty.
    Goyal S; Warner DB
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):1025-7. PubMed ID: 22576371
    [No Abstract]   [Full Text] [Related]  

  • 12. Brevundimonas vesicularis keratitis after laser in situ keratomileusis.
    Pelletier JS; Ide T; Yoo SH
    J Cataract Refract Surg; 2010 Feb; 36(2):340-3. PubMed ID: 20152619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical issues in the treatment of bacterial keratitis.
    Gritz DC; Whitcher JP
    Int Ophthalmol Clin; 1998; 38(4):107-14. PubMed ID: 10081727
    [No Abstract]   [Full Text] [Related]  

  • 14. Vibrio ocular infections on the U.S. Gulf Coast.
    Penland RL; Boniuk M; Wilhelmus KR
    Cornea; 2000 Jan; 19(1):26-9. PubMed ID: 10632004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea.
    Lee SM; Kim MK; Lee JL; Wee WR; Lee JH
    Korean J Ophthalmol; 2008 Mar; 22(1):49-52. PubMed ID: 18323706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Infectious Keratitis Caused by Propionibacterium Acnes.
    Lim SA; Na KS; Joo CK
    Eye Contact Lens; 2017 Sep; 43(5):330-333. PubMed ID: 27203796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection.
    Horseman MA; Surani S
    Int J Infect Dis; 2011 Mar; 15(3):e157-66. PubMed ID: 21177133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial keratitis secondary to infection with Citrobacter koseri.
    Goold LA; Warrier SK; Wittles NK; Nathan F
    Cornea; 2010 Apr; 29(4):479. PubMed ID: 20164753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.